Dr Isaac Eliaz discusses how Galectin-3 is implicated in disease development, as well as the research and ramifications of using modfied citrus protein in the treatment of various disease states, including sepsis, cancer, and autoimmunity.
A look at the first study to evaluate tubulin as a target of curcumin against Giardia trophozoites.
Recent research explored whether there is a relationship between proton pump inhibitor (PPI) use in irritable bowel syndrome (IBS) and small intestinal bacterial overgrowth (SIBO).
It is estimated that the global prevalence of IBS is 11%. The most common cause of IBS is small intestinal bacterial overgrowth (SIBO) — in fact, a whopping 60-80% of IBS is due to this common condition, totalling a possible 500 million people worldwide.
What are the differences in gut bacteria from an obese person to a lean person? Scientists are starting to explore this further.
In this podcast Dr Matthew Ball talks to Andrew about the art and the science that goes into crafting kombucha beverages and the journey creating the brand Wild Kombucha.
Alessandra covers off important areas of naturopathic care in paediatric cases, from safety considerations and assessment techniques to navigating the palatability of treatments and working effectively with their doctors and parents.
Dr Steven Sandberg-Lewis is a leading pioneer in the field of SIBO and other functional gastrointestinal disorders. Today he shares his insights on the IBS - SIBO connection.